The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film-Reference-Cited by-同舟云学术

The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film

Published:2015-09-01 Issue:1 Volume:35 Page:76-82
ISSN:0959-5236
Container-title:Drug and Alcohol Review
language:en
Short-container-title:Drug Alcohol Rev

Author:

White Nancy¹^ORCID,Ali Robert¹,Larance Briony²,Zador Deborah²,Mattick Richard P.²,Degenhardt Louisa²

Affiliation:

1. Discipline of Pharmacology; School of Medical Sciences; University of Adelaide; Adelaide Australia

2. National Drug and Alcohol Research Centre; University of New South Wales; Sydney Australia

Funder

National Health and Medical Research Council Research Fellowships

Australian Government

Publisher

Wiley

Subject

Health(social science),Medicine (miscellaneous)

Reference24 articles.

1. Co-occurring mental illness and substance use disorder among Australian prisoners;Butler;Drug Alcohol Rev,2011

2. Drug use and opioid substitution treatment for prisoners;Stöver;Harm Reduct J,2010

3. High-risk drug-use practices among a large sample of Australian prisoners;Kinner;Drug Alcohol Depend,2012

4. Australian Institute of Health and Welfare National Opioid Pharmacotherapy Statistics Annual Data Collection 2012 (Drug Treatment Series 20) 2013

5. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study;Larney;BMJ Open,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National consensus statement on opioid agonist treatment in custodial settings;2024-08-20

2. “We don’t even know where it’s kept”: exploring perspectives on naloxone administration by provincial correctional workers in Manitoba, Canada;International Journal of Prison Health;2023-12-15

3. Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictions;Water Research;2023-10

4. Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study;Journal of Substance Use and Addiction Treatment;2023-07

5. Health and correctional staff acceptability of depot buprenorphine in NSW prisons;International Journal of Drug Policy;2023-04